SCHEMBL7931985

SCHEMBL7931985

Cc1cc2c(cc1C=C(c1ccc(C(=O)O)cc1)C(F)(F)F)C(C)(C)CCC2(C)C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 5/20 0.62
RARG P13631 5/20 0.62
RARA P10276 4/20 0.62
RXRA P19793 18/20 0.55
RXRB P28702 10/20 0.55
RXRG P48443 10/20 0.55
MEN1 O00255 1/20 0.53
CYP26A1 O43174 1/20 0.53
ABCB11 O95342 1/20 0.53
ESR1 P03372 1/20 0.53
PGR P06401 1/20 0.53
HTR1A P08908 1/20 0.53
ADRA2A P08913 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
CHRM1 P11229 1/20 0.53
DRD1 P21728 1/20 0.53
TBXA2R P21731 1/20 0.53
SLC6A2 P23975 1/20 0.53
ADRA1A P35348 1/20 0.53
OPRM1 P35372 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7922987 0.83 RARA (0.43) RARBRARGRARARXRARXRB
SCHEMBL7932916 0.81 RXRA (0.69) RARBRARGRARARXRARXRB
SCHEMBL3234003 0.79 RARB (0.64) RARBRARGRARARXRARXRB
SCHEMBL3233993 0.79 RARB (0.64) RARBRARGRARARXRARXRB
SCHEMBL7932710 0.77 RARG (0.38) RARBRARGRARARXRARXRB
SCHEMBL156460 0.77 RARB (1.00) RARBRARGRARARXRARXRB
SCHEMBL10841477 0.77 RARB (1.00) RARBRARGRARARXRARXRB
Hydrochloric Acid SCHEMBL4432609 0.76 RARB (0.97) RARBRARGRARARXRARXRB
SCHEMBL7023945 0.72 RARB (0.55) RARBRARGRARARXRARXRB
SCHEMBL726140 0.72 RXRA (1.00) RARBRARGRARARXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0879223-B1 AROMATIC POLYCYCLIC RETINOID-TYPE DERIVATIVES, METHOD FOR PREPARING SAME, AND USE THEREOF FOR MAKING PHARMACEUTICAL AND COSMETIC COMPOSITIONS CT EUROP DE BIOPROSPECTIVE CEB (FR) 2001-11-07 EP claimed
US-6265423-B1 SKIN DISORDERS; ANTICANCER AGENTS CENTRE EUROPEEN DE BIOPROSPECTIVE-CEB (FR) 2001-07-24 US claimed
US-6265423-B1 SKIN DISORDERS; ANTICANCER AGENTS CENTRE EUROPEEN DE BIOPROSPECTIVE-CEB (FR) 2001-07-24 US disclosed